C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2004
10/21/2004	WO2004089422A2 Methods of treating and monitoring systemic lupus erythematosus in individuals
10/21/2004	WO2004089305A2 Heparin/heparosan synthase from p.multocida, soluble and single action catalysts thereof and methods of making and using same
10/21/2004	WO2004089302A2 Posh polypeptides, complexes and related methods
10/21/2004	WO2004089301A2 Compositions, splice variants and methods relating to colon specific genes and proteins
10/21/2004	WO2004089292A2 Immunomodulatory agents for treatment of inflammatory diseases
10/21/2004	WO2004089285A2 Phosphodiesterase 2a and methods of use
10/21/2004	WO2004089284A2 Targets for tumor growth inhibition
10/21/2004	WO2004089282A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/21/2004	WO2004089189A2 Minimally-invasive imaging of viral gene therapy and presurgical applications thereof
10/21/2004	WO2004089073A2 Inducible breast cancer model
10/21/2004	WO2004089072A2 Non-human mammals and animal cells containing a mutated alpha2/delta1 gene
10/21/2004	WO2004089071A1 Non-human mammals and animal cells containing a mutated alpha2/delta gene
10/21/2004	WO2004089066A1 Manipulation of organic acid biosynthesis and secretion
10/21/2004	WO2004081024A3 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide
10/21/2004	WO2004076620A9 Human antibodies specific for interleukin 15 (il-15)
10/21/2004	WO2004072305A3 Atlastin
10/21/2004	WO2004067708A3 Device and method for fragmenting material by hydrodynamic shear
10/21/2004	WO2004056871A3 Peptides and their use for the treatment of hiv infections
10/21/2004	WO2004052932A3 Antibody (“11c7”) anti nogo a and its pharmaceutical use
10/21/2004	WO2004050691A3 A method for the production of hiv-1 gag virus-like particles
10/21/2004	WO2004046160A3 Amino-lna, thio-lna and alpha-l-oxy-ln
10/21/2004	WO2004044173A3 Cis-prenyltransferases from the rubber-producing plants russian dandelion (taraxacum kok-saghyz) and sunflower (helianthus annus)
10/21/2004	WO2004042025A3 Cell-specific adenovirus vector comprising ebv-specific promoter
10/21/2004	WO2004042023B1 Stem cell libraries
10/21/2004	WO2004040973A3 Organellar targeting of rna and its use in the interruption of environmental gene flow
10/21/2004	WO2004034013A3 Genotoxicity analysis
10/21/2004	WO2004032832A3 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment
10/21/2004	WO2004027038A3 Biological containment system
10/21/2004	WO2004022764A3 Use of malate dehydrogenase for nadh regeneration
10/21/2004	WO2004022715A3 Cloning and characterization of the broad-spectrum resistance gene pi2
10/21/2004	WO2004018385A3 Method for the production of zeaxanthin and/or the biosynthetic intermediates and/or subsequent products thereof
10/21/2004	WO2004017062A8 The method and device for accelerating molecular hybridization by ultrasonic wave
10/21/2004	WO2004016223A3 Assaying compounds or agents for microsomal prostaglandin e synthase or hematopoietic prostaglandin d synthase activity
10/21/2004	WO2004009032A3 Method and composition for treating and preventing hepatitis b infection and symptoms thereof
10/21/2004	WO2004004445A3 Phytoremediation of contaminant compounds via chloroplast genetic engineering
10/21/2004	WO2004003134A3 Antisense inhibition via rnase h-independent reduction in mrna
10/21/2004	WO2003104431A3 Transgenic mammals expressing polyglutamine
10/21/2004	WO2003102219A3 Improved pseudotyped retroviruses
10/21/2004	WO2003102197A8 Transgenic plants with controlled distribution of a trait to progeny
10/21/2004	WO2003043631A3 Method for identification of tumor targeting enzymes
10/21/2004	WO2003027638A8 Methods for detecting genetic mosaicisms using arrays
10/21/2004	WO2003027266A3 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
10/21/2004	WO2003024392A3 Compositions and methods for the diagnosis and treatment of tumor
10/21/2004	WO2002086077A3 Co-expression of zein proteins
10/21/2004	WO1995027066A9 Dna encoding ubiquitin conjugating enzymes
10/21/2004	US20040210967 Genes for controlling floral development in orchid
10/21/2004	US20040210966 Multiple gene expression for engineering novel pathways and hyperexpression of foreign proteins in plants
10/21/2004	US20040210965 Comprises nucleotide sequences coding pesticidal protein for use in transformation and propagation of insect resistant crop plants; tissue engineering and biological pest control
10/21/2004	US20040210964 AXMI-009, a delta-endotoxin gene and methods for its use
10/21/2004	US20040210963 Genes encoding proteins with pesticidal activity
10/21/2004	US20040210962 Nucleotide sequences coding protein associated with controlling mitochondrial recombination for use in identifying RNA sequence which suppress sequence insertion into mitochondrial genomes
10/21/2004	US20040210961 Markerless transformation
10/21/2004	US20040210960 Expression vector comprising nucleotide sequences coding proteins which enhance carbohydrate, protein, fatty acid and/or phytohormone biosynthesis/metabolism for use in transformation and propagation of insect resistance plants; tissue engineering
10/21/2004	US20040210959 A Novel Method for Production of Transformed Dihaploid Corn Plants
10/21/2004	US20040210958 Using nutrient broth growth mixture comprising plant tissue, picloram and 6-benzylaminopurine to generate callus susceptible to gene trans fer protocols; tissue engineering
10/21/2004	US20040210957 Cloning and characterization of the broad-spectrum resistance gene P12
10/21/2004	US20040210956 Preparing expression vector comprising nucleotide sequences coding spider silk protein, transforming arabidopsis and recover protein; plant bioreactors
10/21/2004	US20040210955 Preparation of spermatozoa for ICSI-mediated transgenesis and methods of using the same
10/21/2004	US20040210954 Using homologous recombination to insert/transfer heterologous genomes into birds; tissue engineering and heterologous protein expression
10/21/2004	US20040210953 Lysozyme transgenic ungulates
10/21/2004	US20040210952 Transgenic animals
10/21/2004	US20040210951 Gene silencing
10/21/2004	US20040210950 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (CALSARCINS)
10/21/2004	US20040210043 Seed preferred regulatory elements
10/21/2004	US20040210042 Polypeptides relating to signal transfer of advanced glycation end product receptor
10/21/2004	US20040210040 Monoclonal antibodies for use in the prevention and treatment of cell proliferative and skin disorders; immunotherapy; antitumor agents
10/21/2004	US20040210038 Il-1 eta DNA and polypeptides
10/21/2004	US20040209962 Use of aromatic aldehydes as insecticides
10/21/2004	US20040209942 treating cancer and apoptosis-associated disorders using cell cycle checkpoint activation modulators; also screening for the modulators
10/21/2004	US20040209840 Manipulation of arterial-venous identity
10/21/2004	US20040209839 Human peroxisome proliferator activated receptor gamma
10/21/2004	US20040209838 Antisense oligonucleotide which inhibits gene coding diacylglycerol acyltransferase for use in diagnosis, prevention and treatment of abnormal cholesterol, hyperlipidemia, diabetes, obesity and cardiovascular disease
10/21/2004	US20040209836 activation of antigen-presenting cells; modifying dendritic cells to express an inducible form of a co-stimulatory polypeptide molecule; used to bolster the immune response of an immunocompromised subject, such as an HIV-infected subject
10/21/2004	US20040209835 Process for preparing purified nucleic acid and the use thereof
10/21/2004	US20040209834 mouse double minute (MDM); determining the mdm2-dependent growth activity of a cell by introducing vectors for expressing a p53 polypeptide or fragment into the cell, and measuring the growth of the cell
10/21/2004	US20040209833 Transgenic fish germline expression driven by liver fatty acid binding (L-FABP) gene promoter and applications thereof
10/21/2004	US20040209832 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
10/21/2004	US20040209831 RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)
10/21/2004	US20040209817 Methods and compositions for the treatment of peripheral artery disease
10/21/2004	US20040209799 comprises inhibitors (cytokines) of janus kinases (JAK)/signal transducers and activators of transcription (STAT) other than debromohymenialdisine and hymensialdisine; gene expression inhibition; bioassay, immunoassay, drug screening; for treatment of degenerative joint diseases such as osteoarthritis
10/21/2004	US20040209797 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells
10/21/2004	US20040209370 Integrating of foreign genetic elements into a bacterial chromosome without the need of cloning; genomic insertion via recombinase
10/21/2004	US20040209369 Controlling gene expression in living cells
10/21/2004	US20040209368 Preparing transgenic bacteria with enhanced ubiquinone production
10/21/2004	US20040209367 Mutagenesis technique
10/21/2004	US20040209366 Methods for attaching proteins to lipidic microparticles with high efficiency
10/21/2004	US20040209365 Parallel chromosomal stacking of traits in bacteria
10/21/2004	US20040209364 Enhancced adeno-associated viral vector for use as gene transfer tool in genetic engineering and gene therapy; antitumor agents
10/21/2004	US20040209362 Electrocompetent host cells
10/21/2004	US20040209358 Oligonucleotide sequences for use in controlling gene expression of serum response factor accessory protein-1 (SAP-I) gene for use in treatment of cell proliferative disorders; gene therapy and antiproliferfative agents; gene expression inhibition
10/21/2004	US20040209356 incubating isomaltulose with sorbitol dehydrogenase; host cells
10/21/2004	US20040209345 cyanide resistant; cultured from rhodococcus; for producing 2-hydroxy-4-methylthiobutyroamide from hydroxy nitrile compounds
10/21/2004	US20040209342 Comprises nucleotide sequences coding hydrolase for use in identifying modulators for treatment of diabetes and inflammatory diseases
10/21/2004	US20040209341 Plant amino acid biosynthetic enzymes
10/21/2004	US20040209337 Synthesis of 1,2,3,4-tetrahydroxybenzenes from biomass-derived carbon
10/21/2004	US20040209332 Process for manufacturing morpholino-nucleotides, and use thereof for the analysis of and labelling of nucleic acid sequences
10/21/2004	US20040209331 Thermal cycling system and method of use
10/21/2004	US20040209329 Nucleotide sequences coding insecticidal protein membrane receptor for use in generating insect resistant plants; biological pest control; drug screening and design
10/21/2004	US20040209327 Regulation of human transmembrane serine protease
10/21/2004	US20040209326 Immunoglobulin for use in detection and prevention staphylococcus infections

1 ... 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 ... 4023